T. Vanderpoll et al., HYPERCORTISOLEMIA INCREASES PLASMA INTERLEUKIN-10 CONCENTRATIONS DURING HUMAN ENDOTOXEMIA - A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3604-3606
Hypercortisolemia directly before the administration of endotoxin (LPS
) to normal humans completely prevents the release of the proinflammat
ory cytokine tumor necrosis factor, whereas hypercortisolemia 12 h to
7 days before the injection of LPS is associated with enhanced tumor n
ecrosis factor release. To determine the effect of elevated cortisol l
evels on the secretion of the antiinflammatory cytokine interleukin-10
(IL-10), 23 healthy men were given iv LPS (lot EC-5; 2 ng/kg) done or
in combination with a continuous iv infusion of hydrocortisone (3 mu
g/kg . min) for 6 h immediately before or 6, 12, or 144 h before LPS i
njection. LPS induced a monophasic increase in plasma IL-10 concentrat
ions that peaked after 2 h (162 +/- 27 pg/mL; P < 0.0001). In subjects
who were infused with hydrocortisone directly before LPS administrati
on, IL-10 concentrations were much higher (1784 +/- 331 pg/mL; P < 0.0
001 vs. LPS only), whereas hypercortisolemia 6, 12, or 144 h before LP
S injection did not influence LPS-induced IL-10 levels. In human whole
blood in vitro, hydrocortisone caused a dose-dependent reduction of L
PS-induced IL-10 levels. Further, hydrocortisone reversed the increase
in IL-10 concentrations by epinephrine in LPS-stimulated whole blood.
Stimulation of IL-10 release may contribute to the antiinflammatory p
roperties of glucocorticoids.